Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0IQNVH
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
PRO-1102
|
|||||
| Synonyms |
PRO 1102; PRO1102
Click to Show/Hide
|
|||||
| Organization |
ProfoundBio (Suzhou) Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
Exatecan
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Cleavable hydrophilic linker
|
Linker Info | ||||
